<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39363958</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2753-4294</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>BMJ public health</Title><ISOAbbreviation>BMJ Public Health</ISOAbbreviation></Journal><ArticleTitle>Evaluating COVID-19 vaccine effectiveness during pre-Delta, Delta and Omicron dominant periods among pregnant people in the U.S.: Retrospective cohort analysis from a nationally sampled cohort in National COVID Collaborative Cohort (N3C).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000770</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjph-2023-000770</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To evaluate the effectiveness of COVID-19 vaccinations (initial and booster) during pre-Delta, Delta, and Omicron dominant periods among pregnant people via (1) COVID-19 incident and severe infections among pregnant people who were vaccinated vs. unvaccinated and (2) post-COVID-19 vaccination breakthrough infections and severe infections among vaccinated females who were pregnant vs. non-pregnant.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Retrospective cohort study using nationally sampled electronic health records data from the National COVID Cohort Collaborative (N3C), December 10, 2020, to June 07, 2022.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">Cohort 1 included pregnant people (15-55 years), and Cohort 2 included vaccinated females of reproductive age (15-55 years).</AbstractText><AbstractText Label="EXPOSURES" NlmCategory="UNASSIGNED">(1) COVID-19 vaccination and (2) pregnancy.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="UNASSIGNED">Adjusted hazard ratios (aHRs) for COVID-19 incident or breakthrough infections and severe infections (i.e., COVID-19 infections with related hospitalizations).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In Cohort 1, 301,107 pregnant people were included. Compared to unvaccinated pregnant people, the aHRs for pregnant people with initial vaccinations <i>during</i> pregnancy of incident COVID-19 were 0.77 (95% CI: 0.62, 0.96) and 0.88 (95%CI: 0.73, 1.07) and aHRs of severe COVID-19 infections were 0.65 (95% CI: 0.47, 0.90) and 0.79 (95% CI: 0.51, 1.21) during the Delta and Omicron periods, respectively. Compared to pregnant people with full initial vaccinations, the aHR of incident COVID-19 for pregnant people with booster vaccinations was 0.64 (95% CI: 0.58, 0.71) during the Omicron period. In Cohort 2, 934,337 vaccinated people were included. Compared to vaccinated non-pregnant females, the aHRs of severe COVID-19 infections for people with initial vaccinations <i>during</i> pregnancy was 2.71 (95% CI: 1.31, 5.60) during the Omicron periods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Pregnant people with initial and booster vaccinations during pregnancy had a lower risk of incident and severe COVID-19 infections compared to unvaccinated pregnant people across the pandemic stages. However, vaccinated pregnant people still had a higher risk of severe infections compared to non-pregnant females.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Qiuyuan Crystal</ForeName><Initials>QC</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Kenneth J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Biostatistics Program / Office of Clinical Research Support, Office of the Director, National Institute of Diabetes &amp; Digestive &amp; Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Office of Data Science and Emerging Technologies, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradwell</LastName><ForeName>Katie R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anzalone</LastName><ForeName>Jerrod</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA; Great Plains IDeA-CTR, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Qulu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebman</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IPQ Analytics, LLC, Kennett Square, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariona</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Beaumont Hospital-Dearborn, Dearborn, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faherty</LastName><ForeName>Emily A Groene</ForeName><Initials>EAG</Initials><AffiliationInfo><Affiliation>University of Minnesota School of Public Health, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Challa</LastName><ForeName>Anup P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Rena C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Medicine and Global Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine and Public Health, University of Alabama Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001427</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115371</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH131542</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001409</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>INV-018455</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Public Health</MedlineTA><NlmUniqueID>9918697578906676</NlmUniqueID><ISSNLinking>2753-4294</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">pregnant people</Keyword><Keyword MajorTopicYN="N">vaccine effectiveness</Keyword></KeywordList><CoiStatement>Conflicts of Interest and Disclaimers APC helped to conceptualize this study while at Vanderbilt University. Following this contribution, APC joined the staff of AstraZeneca Pharmaceuticals, LP (“AZ”), which markets a COVID-19 vaccine in direct competition to other products considered in this manuscript. After joining AZ, APC did not participate in the conduct of this research, with his subsequent contributions limited to ad hoc consultation on methods for real-world data management, as part of routine meetings of the N3C Pregnancy Domain Team for which he is an advisor. APC did not provide any guidance on product-specific or advocacy topics. Similarly, AZ did not provide any data, funding, or scientific input towards the results herein. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health, AZ, or the N3C program.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363958</ArticleId><ArticleId IdType="mid">NIHMS2025322</ArticleId><ArticleId IdType="pmc">PMC11449158</ArticleId><ArticleId IdType="doi">10.1136/bmjph-2023-000770</ArticleId><ArticleId IdType="pii">e000770</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnson AG, “COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4-December 25, 2021,” MMWR Morb. Mortal. Wkly. Rep, vol. 71, 2022, doi: 10.15585/mmwr.mm7104e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7104e2</ArticleId><ArticleId IdType="pmc">PMC9351531</ArticleId><ArticleId IdType="pubmed">35085223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J et al., “Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US,” JAMA Intern. Med, vol. 182, no. 2, pp. 153–162, Feb. 2022, doi: 10.1001/jamainternmed.2021.7024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.7024</ArticleId><ArticleId IdType="pmc">PMC8715386</ArticleId><ArticleId IdType="pubmed">34962505</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal U et al., “Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales,” The Lancet, vol. 400, no. 10360, pp. 1305–1320, Oct. 2022, doi: 10.1016/S0140-6736(22)01656-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01656-7</ArticleId><ArticleId IdType="pmc">PMC9560746</ArticleId><ArticleId IdType="pubmed">36244382</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashraath P et al., “Coronavirus disease 2019 (COVID-19) pandemic and pregnancy,” Am. J. Obstet. Gynecol, vol. 222, no. 6, pp. 521–531, Jun. 2020, doi: 10.1016/j.ajog.2020.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.03.021</ArticleId><ArticleId IdType="pmc">PMC7270569</ArticleId><ArticleId IdType="pubmed">32217113</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC, “Pregnant and Recently Pregnant People,” Centers for Disease Control and Prevention. Accessed: May 04, 2022. [Online]. Available: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html</Citation></Reference><Reference><Citation>Lv D
et al., “Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era,” Front. Immunol, vol. 12, 2021, Accessed: May 04, 2022. [Online]. Available: https://www.frontiersin.org/article/10.3389/fimmu.2021.683440</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.683440</ArticleId><ArticleId IdType="pmc">PMC8298030</ArticleId><ArticleId IdType="pubmed">34305916</ArticleId></ArticleIdList></Reference><Reference><Citation>McClymont E et al., “Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes,” JAMA, May 2022, doi: 10.1001/jama.2022.5906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.5906</ArticleId><ArticleId IdType="pmc">PMC9062768</ArticleId><ArticleId IdType="pubmed">35499852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurol-Urganci I et al., “Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study,” Am. J. Obstet. Gynecol, vol. 225, no. 5, p. 522.e1–522.e11, Nov. 2021, doi: 10.1016/j.ajog.2021.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.05.016</ArticleId><ArticleId IdType="pmc">PMC8135190</ArticleId><ArticleId IdType="pubmed">34023315</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow AG, Castro VM, Shook LL, Kaimal AJ, and Perlis RH, “Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy,” JAMA Netw. Open, vol. 5, no. 6, p. e2215787, Jun. 2022, doi: 10.1001/jamanetworkopen.2022.15787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.15787</ArticleId><ArticleId IdType="pmc">PMC9185175</ArticleId><ArticleId IdType="pubmed">35679048</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong S, Jang EJ, Jo J, and Jang S, “Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis,” PLoS ONE, vol. 14, no. 8, p. e0220910, Aug. 2019, doi: 10.1371/journal.pone.0220910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0220910</ArticleId><ArticleId IdType="pmc">PMC6693758</ArticleId><ArticleId IdType="pubmed">31412058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohfuji S et al., “Safety of influenza vaccination on adverse birth outcomes among pregnant women: A prospective cohort study in Japan,” Int. J. Infect. Dis, vol. 93, pp. 68–76, Apr. 2020, doi: 10.1016/j.ijid.2020.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.01.033</ArticleId><ArticleId IdType="pubmed">31982621</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarvis JR, Dorey RB, Warricker FDM, Alwan NA, and Jones CE, “The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis,” Vaccine, vol. 38, no. 7, pp. 1601–1613, Feb. 2020, doi: 10.1016/j.vaccine.2019.12.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.12.056</ArticleId><ArticleId IdType="pubmed">31932138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharbanda EO and Vazquez-Benitez G, “COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy,” JAMA, vol. 327, no. 15, pp. 1451–1453, Apr. 2022, doi: 10.1001/jama.2022.2459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2459</ArticleId><ArticleId IdType="pubmed">35325030</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, and Håberg SE, “Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage,” N. Engl. J. Med, vol. 385, no. 21, pp. 2008–2010, Nov. 2021, doi: 10.1056/NEJMc2114466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2114466</ArticleId><ArticleId IdType="pmc">PMC8552533</ArticleId><ArticleId IdType="pubmed">34670062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipkind HS et al., “Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021,” MMWR Morb. Mortal. Wkly. Rep, vol. 71, no. 1, pp. 26–30, Jan. 2022, doi: 10.15585/mmwr.mm7101e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7101e1</ArticleId><ArticleId IdType="pmc">PMC8735559</ArticleId><ArticleId IdType="pubmed">34990445</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldshtein I et al., “Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes,” JAMA Pediatr, vol. 176, no. 5, pp. 470–477, May 2022, doi: 10.1001/jamapediatrics.2022.0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.0001</ArticleId><ArticleId IdType="pmc">PMC8832306</ArticleId><ArticleId IdType="pubmed">35142809</ArticleId></ArticleIdList></Reference><Reference><Citation>Faherty EAG et al., “Pregnancy Outcomes among Pregnant Persons after COVID-19 Vaccination: Assessing Vaccine Safety in Retrospective Cohort Analysis of U.S. National COVID Cohort Collaborative (N3C),” Vaccines, vol. 12, no. 3, Art. no. 3, Mar. 2024, doi: 10.3390/vaccines12030289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12030289</ArticleId><ArticleId IdType="pmc">PMC10975285</ArticleId><ArticleId IdType="pubmed">38543923</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratama NR, Wafa IA, Budi DS, Putra M, Wardhana MP, and Wungu CDK, “mRNA Covid-19 vaccines in pregnancy: A systematic review,” PLOS ONE, vol. 17, no. 2, p. e0261350, Feb. 2022, doi: 10.1371/journal.pone.0261350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261350</ArticleId><ArticleId IdType="pmc">PMC8809595</ArticleId><ArticleId IdType="pubmed">35108277</ArticleId></ArticleIdList></Reference><Reference><Citation>Burd I, Kino T, and Segars J, “The Israeli study of Pfizer BNT162b2 vaccine in pregnancy: considering maternal and neonatal benefits,” J. Clin. Invest, vol. 131, no. 13, p. 150790, Jul. 2021, doi: 10.1172/JCI150790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150790</ArticleId><ArticleId IdType="pmc">PMC8245166</ArticleId><ArticleId IdType="pubmed">34101621</ArticleId></ArticleIdList></Reference><Reference><Citation>Theiler RN, Wick M, Mehta R, Weaver AL, Virk A, and Swift M, “Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy,” Am. J. Obstet. Gynecol. Mfm, vol. 3, no. 6, p. 100467, Nov. 2021, doi: 10.1016/j.ajogmf.2021.100467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2021.100467</ArticleId><ArticleId IdType="pmc">PMC8378017</ArticleId><ArticleId IdType="pubmed">34425297</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldshtein I et al., “Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women,” JAMA, vol. 326, no. 8, pp. 728–735, Aug. 2021, doi: 10.1001/jama.2021.11035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11035</ArticleId><ArticleId IdType="pmc">PMC8276131</ArticleId><ArticleId IdType="pubmed">34251417</ArticleId></ArticleIdList></Reference><Reference><Citation>MD DL, Barkley E, Kibitel J, PharmD NC, and McNitt J, “Which Comorbidities Increase the Risk of a COVID-19 Breakthrough Infection?,” Epic Research. Accessed: May 04, 2022. [Online]. Available: https://epicresearch.org/articles/which-comorbidities-increase-the-risk-of-a-covid-19-breakthrough-infection</Citation></Reference><Reference><Citation>Jones SE et al., “Who is pregnant? Defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C),” JAMIA Open, vol. 6, no. 3, p. ooad067, Aug. 2023, doi: 10.1093/jamiaopen/ooad067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooad067</ArticleId><ArticleId IdType="pmc">PMC10432357</ArticleId><ArticleId IdType="pubmed">37600074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett TD et al., “Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative,” JAMA Netw. Open, vol. 4, no. 7, p. e2116901, Jul. 2021, doi: 10.1001/jamanetworkopen.2021.16901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16901</ArticleId><ArticleId IdType="pmc">PMC8278272</ArticleId><ArticleId IdType="pubmed">34255046</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA et al., “The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment,” J. Am. Med. Inform. Assoc. JAMIA, vol. 28, no. 3, pp. 427–443, Mar. 2021, doi: 10.1093/jamia/ocaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>“Clinical Guidance for COVID-19 Vaccination ∣ CDC.” Accessed: Oct. 02, 2023. [Online]. Available: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html</Citation></Reference><Reference><Citation>Lambrou AS, “Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022,” MMWR Morb. Mortal. Wkly. Rep, vol. 71, 2022, doi: 10.15585/mmwr.mm7106a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7106a4</ArticleId><ArticleId IdType="pmc">PMC8830620</ArticleId><ArticleId IdType="pubmed">35143464</ArticleId></ArticleIdList></Reference><Reference><Citation>“Trends in Length of Stay for Hospital Deliveries -- United States, 1970–1992.” Accessed: Oct. 02, 2023. [Online]. Available: https://www.cdc.gov/mmwr/preview/mmwrhtml/00036988.htm</Citation></Reference><Reference><Citation>Fendler A et al., “COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety,” Nat. Rev. Clin. Oncol, vol. 19, no. 6, Art. no. 6, Jun. 2022, doi: 10.1038/s41571-022-00610-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-022-00610-8</ArticleId><ArticleId IdType="pmc">PMC8916486</ArticleId><ArticleId IdType="pubmed">35277694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirtaleb MS et al., “An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations,” Int. Immunopharmacol, vol. 117, p. 109934, Apr. 2023, doi: 10.1016/j.intimp.2023.109934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.109934</ArticleId><ArticleId IdType="pmc">PMC9968612</ArticleId><ArticleId IdType="pubmed">36867924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan J et al., “Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study,” PLOS Med, vol. 20, no. 1, p. e1004153, Jan. 2023, doi: 10.1371/journal.pmed.1004153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004153</ArticleId><ArticleId IdType="pmc">PMC9876273</ArticleId><ArticleId IdType="pubmed">36626376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H et al., “Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study,” Lancet Infect. Dis, vol. 23, no. 7, pp. 816–827, Jul. 2023, doi: 10.1016/S1473-3099(23)00058-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00058-0</ArticleId><ArticleId IdType="pmc">PMC10079373</ArticleId><ArticleId IdType="pubmed">36913963</ArticleId></ArticleIdList></Reference><Reference><Citation>Plumb ID et al., “Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022,” Open Forum Infect. Dis, vol. 10, no. 10, p. ofad457, Oct. 2023, doi: 10.1093/ofid/ofad457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad457</ArticleId><ArticleId IdType="pmc">PMC10549208</ArticleId><ArticleId IdType="pubmed">37799130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellington S and Olson CK, “Safety of mRNA COVID-19 vaccines during pregnancy,” Lancet Infect. Dis, vol. 22, no. 11, pp. 1514–1515, Nov. 2022, doi: 10.1016/S1473-3099(22)00443-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00443-1</ArticleId><ArticleId IdType="pmc">PMC9371585</ArticleId><ArticleId IdType="pubmed">35964615</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland C, Hammond C, and Richmond MM, “COVID-19 and Pregnancy: Risks and Outcomes,” Nurs. Womens Health, vol. 27, no. 1, pp. 31–41, Feb. 2023, doi: 10.1016/j.nwh.2022.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nwh.2022.11.004</ArticleId><ArticleId IdType="pmc">PMC9749909</ArticleId><ArticleId IdType="pubmed">36528073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>